x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The BioHub - by Avetix

Max Brennan - Biotech HeadHunter

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that"s shaping the future of biotechnology. Get ready for an immersive

science life sciences

All Episodes

00:22:57

Episode 145 - Ashley Zehnder - CEO Fauna Bio

The BioHub - by Avetix ·

2026/04/10

Today’s guest is Ashley Zehnder, the co-founder and CEO of Fauna Bio—a pioneering biotech company unlocking insights from the natural world to transform human health.With a background in genomics and a passion for translating cutting-edge science into real-world therapies, Ashley is leading a new frontier in drug discovery—one that looks to nature’s own evolutionary experiments to uncover novel treatments for disease.Under her leadership, Fauna Bio is redefining how we approach medicine by combining

en

00:25:33

Episode 144 - Robert Jacks - CEO Sparrow Pharmaceuticals

The BioHub - by Avetix ·

2026/04/10

In this episode of The BioHub Podcast, Max sits down with Robert Jacks, President and CEO of Sparrow Pharmaceuticals.Robert brings more than 25 years of experience in biotech, having founded or co-founded multiple companies and raised over $300 million across his career. From roles in corporate development at Pfizer to leading companies through development, approval, and exit, he’s seen the industry from every angle.In this conversation, Robert shares his journey into biotech leadership, the story

en

00:13:53

Episode 143 - Jenny Yang - CEO & Co-Founder at...

The BioHub - by Avetix ·

2026/04/09

In this episode, we’re joined by Jenny Yang, Founder and CEO of Outpost Bio, a company building an AI-driven platform to understand how the human microbiome interacts with drugs, food, and other interventions.Jenny shares her journey from machine learning and genomics research through to her PhD at the University of Oxford and experience at Exscientia, before founding Outpost Bio.We discuss why the microbiome remains an underexplored layer in drug discovery, how advances in AI are enabling more

en

00:29:39

Episode 142 - Cary Claiborne - CEO of Adial Pharma

The BioHub - by Avetix ·

2026/04/02

In this episode of The BioHub Podcast, Max sits down with Cary Claiborne, CEO of Adial Pharmaceuticals.Cary’s career spans finance, M&A, and leadership across multiple public biotech companies before stepping into the CEO role at Adial. The company is focused on developing genetically targeted therapies for addiction, starting with alcohol use disorder.In this conversation, Cary shares his transition into biotech leadership, what it’s like running a micro-cap clinical-stage company, and how

en

00:46:55

Episode 141 - Spyros Papapetropoulos - CEO Phragma...

The BioHub - by Avetix ·

2026/04/01

Today’s guest brings one of the broadest and most thoughtful perspectives in neuroscience, spanning clinical practice, drug development, investing, and company building.Dr. Spyros Papapetropoulos is a neurologist, neuroscientist, and biotech leader who has spent his career at the intersection of science, medicine, and innovation. With deep experience across both large pharma and emerging biotech, he has built a reputation for translating complex neuroscience into clear strategic direction - helping

en

00:33:03

Episode 140 - Megan McGill - CEO Brenig Therapeutics

The BioHub - by Avetix ·

2026/04/01

Today’s guest brings a rare blend of medicine, science, and strategy to the frontlines of biotech innovation.Dr. Megan McGill is a physician-scientist and biotech leader with over two decades of experience spanning clinical medicine, neuroscience research, and drug development. Trained as both an MD and PhD, her work has focused deeply on understanding the brain—particularly the mechanisms behind neurodegenerative diseases like Parkinson’s.But Megan didn’t stop at the lab or the clinic. She’s also

en

00:10:21

Episode 139 - Tess Bevers - CEO & Founder - Novogaia

The BioHub - by Avetix ·

2026/03/31

In this episode of The Biohub Podcast, Amber sits down with Tess Bevers CEO and Founder of Novogaia, a company combining AI and mass spectrometry to discover new drug molecules from fungi.We explore why fungi remain one of the most underexplored sources of chemistry in nature, the historical bottlenecks in natural product drug discovery, and how new advances in AI are helping researchers prioritise which molecules could actually become viable drugs.Tess also shares how Novogaia is building its

en

00:28:58

Episode 138- Jason Tardio - COO - Immunic Therapeutics

The BioHub - by Avetix ·

2026/03/31

Welcome to another episode of The BioHub.Today I’m joined by Jason Tardio —COO of Immunic Therapeutics, a clinical stage biotech for oral small molecule therapies for chronic inflammatory and autoimmune diseases. In this episode we explore Jason's awesome background, from starting as a sales rep and climbing the ladder into his position today, as COO.

en

00:28:27

Episode 137 - Steffen-Sebastian Bolz - Co-founder of...

The BioHub - by Avetix ·

2026/03/30

Welcome to another episode of The BioHub.Today I’m joined by Steffen-Sebastian Bolz — scientist, physician, entrepreneur, and Co-Founder of Aphaia Pharma, a clinical-stage biotech developing precision-targeted drug formulations to treat and prevent metabolic disorders like obesity and prediabetes.We’ll be talking about the science behind Aphaia, why they’re not building with an exit in mind, and how staying lean and under the radar has helped them advance to Phase 2.

en

00:23:09

Episode 136 - Philippe Chambon - CEO & Co-Founder EG427

The BioHub - by Avetix ·

2026/03/25

In this episode of The BioHub Podcast, Max sits down with Dr. Philippe Chambon, CEO and Co-Founder of EG 427.After more than 30 years in pharma and venture capital — raising over $1 billion to back life science companies — Philippe has made the move from investor to operator, now leading EG 427.The company is pioneering a new approach to neurological disease with pinpoint DNA medicine, designed for precise and durable delivery.In this conversation, Philippe shares his journey into the CEO seat, the

en

00:27:54

Episode 135 - Yerem Yeghiazarians - Co-Founder & CEO...

The BioHub - by Avetix ·

2026/03/25

Today’s guest is Dr. Yerem Yeghiazarians — a leading interventional cardiologist, professor of medicine at the University of California, San Francisco, and a physician-scientist working at the cutting edge of cardiovascular innovation.With medical training from Johns Hopkins and advanced cardiology specialization at Brigham and Women’s Hospital, Dr. Yeghiazarians has spent over two decades at UCSF treating complex heart disease and advancing the field of interventional cardiology.Dr. Yeghiazarians

en

00:35:12

Episode 134 - Amit Etkin - Founder & CEO Alto...

The BioHub - by Avetix ·

2026/03/20

In this episode of The BioHub Podcast, Max sits down with Amit Etkin, Founder and CEO of Alto Neuroscience.Psychiatry is one of the few areas in medicine still dominated by trial and error.Amit is trying to change that.A trained psychiatrist and neuroscientist, Amit founded Alto to bring precision medicine into mental health — using biomarkers to better match patients with the treatments that actually work for them.In this conversation, we get into why CNS drug development has historically

en

00:23:09

Episode 133 - Ronald Li & James Kim - CEO and Chief...

The BioHub - by Avetix ·

2026/03/19

We were delighted to be joined by James Kim (Chief Corporate Officer) and Ronald Li (Chief Executive Officer), at Medera Biopharmaceuticals.Medera is a company at the forefront of pharmaceutical innovation, focused on advancing next-generation therapies and building a globally competitive platform across research, development, and commercialization. As the industry continues to evolve — driven by scientific breakthroughs, regulatory complexity, and shifting market dynamics — Medera is positioning

en

00:24:18

Episode 132 - Fabian Gerlinghaus - Co-Founder & CEO...

The BioHub - by Avetix ·

2026/03/18

On this episode we welcome Cellares' co-founder, Fabian Gerlinghaus, to discuss their revolutionary, fully automated, cell therapy manufacturing platform.Cell therapies work - the science is proven. Fabian & the team's mission is to deliver these life-changing therapies at scale, to change more patient's lives.On this episode we talk through Fabian's background in robotics, his move to California and the life sciences, and how he and co-founder Omar Kurdi started the Cellares

en

00:53:12

Episode 131 - Dipal Doshi - CEO of Entrada Therapeutics

The BioHub - by Avetix ·

2026/03/17

Today, we’re joined by Dipal Doshi, a leader at theforefront of modern biotechnology and rare disease innovation. As CEO of Entrada Therapeutics, Dipal has helped build the company from its earliest days into a clinical-stage pioneer focused on unlocking intracellular therapies.With a career that spans investment banking at MerrillLynch, global pharma at Eli Lilly and Company, and senior leadership roles at Amicus Therapeutics, Dipal brings a unique blend of financial, strategic, and commercial

en

00:29:43

Episode 130 - Barry Quart - CEO Connect Biopharma

The BioHub - by Avetix ·

2026/03/16

In this episode of The BioHub Podcast, Max sits down with Barry Quart, CEO of Connect Biopharma and one of the most experienced biotech leaders in the industry.Barry’s career spans more than three decades across biotech and pharma, including founding Ardea Biosciences (acquired by AstraZeneca) and leading Heron Therapeutics, where he helped bring multiple drugs through development and approval. Across his career he has played a role in nine FDA-approved medicines.In this conversation, Barry shares

en

00:26:44

Episode 129 - Bob Clarke - CEO & Co-Founder at...

The BioHub - by Avetix ·

2026/03/12

Today’s guest is Robert Clarke, the CEO of Kinaset — acompany at the forefront of next-generation therapeutics and biotechnology innovation.Robert brings a unique blend of scientific curiosity, strategic leadership, and entrepreneurial drive to the biotech world. With a background spanning life sciences, investment, and company building, he has spent much of his career working at the intersection of science and commercialization — helping translate breakthrough research into real-world medical

en

00:20:17

Episode 128 - Emily Gransky - VP, Talent @ Formation Bio

The BioHub - by Avetix ·

2026/03/11

The biggest bottleneck in drug development is no longer discovery, it's in the clinic. Formation Bio's proprietary AI-native platform is changing drug development to bring new treatments to patients faster and more efficiently.We catch up with Emily Gransky, who is shaping the talent strategy behind one of biotechs most exciting stories.Emily previously shaped Flagship & RA Ventures TA strategies, and played a key role in scaling Bluebird Bio from 300 to 800 headcount.During this

en

00:28:09

Episode 127 - Ann Belien - Founder and CEO Rejuvenate...

The BioHub - by Avetix ·

2026/03/10

Ann is the Founder and CEO of Rejuvenate Biomed, a clinical-stage biotechnology company developing combination therapies aimed at targeting the biological mechanisms behind age-related diseases. With more than two decades of experience in pharmaceutical research and development, she has built a career focused on translating cutting-edge science into therapies that can improve patients’ lives.Before launching Rejuvenate Biomed in 2017, Ann held leadership roles at Janssen Pharmaceuticals, part of

en

00:25:45

Episode 126 - Catherine Isted - CFO of Santhera...

The BioHub - by Avetix ·

2026/03/09

In this episode of The BioHub, I’m joined by Catherine Isted, Chief Financial Officer of Santhera Pharmaceuticals.Catherine’s career journey is a unique one, from starting as a bench scientist, to nearly two decades in healthcare investment banking, and now leading finance at multiple biotech companies.In this International Women’s Day special, we talk about her path through the industry, the importance of diversity of thought in biotech, her experiences building a career in leadership, and her

en

171 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter